Last reviewed · How we verify
cicaderma + simple hygiene rules
Cicaderma is a topical treatment that combines cicatricial and anti-inflammatory properties to promote wound healing and improve skin hydration.
Cicaderma is a topical treatment that combines cicatricial and anti-inflammatory properties to promote wound healing and improve skin hydration. Used for Treatment of dry skin and wound healing.
At a glance
| Generic name | cicaderma + simple hygiene rules |
|---|---|
| Also known as | Cicaderma ointment and simple hygiene rules |
| Sponsor | Centre Leon Berard |
| Drug class | Topical treatment |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
Cicaderma's mechanism of action involves the stimulation of collagen synthesis, improvement of skin elasticity, and reduction of inflammation. This is achieved through the combination of cicatricial and anti-inflammatory agents, which work synergistically to promote wound healing and improve skin health.
Approved indications
- Treatment of dry skin and wound healing
Common side effects
- Skin irritation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- cicaderma + simple hygiene rules CI brief — competitive landscape report
- cicaderma + simple hygiene rules updates RSS · CI watch RSS
- Centre Leon Berard portfolio CI